Maintain JPM at benchmark weight; tiered adds at $346 and $335, hard exit at $317
Maintain JPM at benchmark weight. The asymmetric risk/reward at $357.62 (~3% upside to upper Bollinger $365.99 vs ~3.2% downside to 50-DMA $346) does not justify fresh capital deployment, while the 17.79% ROE franchise floor prevents reducing below benchmark weight. Pre-commit to tiered adds at $346 and $335 so routine pullbacks improve entry mechanically rather than discretionarily. Defer second tranche past GSIB resolution (H2-26) to avoid binary event risk. Q3-26 earnings mid-October resolves Q2 comp-distortion, NII trajectory under no-cut pricing, and credit-card delinquency disclosure — the mandatory reassessment gate.
| Position | Action |
|---|---|
| Retest of $365–$367 without fresh catalysts | Trim 10–15% |
| At $346 (50-DMA) | Add Tranche 1 (50%) |
| At $335 or post-GSIB basing pattern | Add Tranche 2 (50%) |
| Hard exit at $317 (200-DMA) on volume | Exit entire position |
JPMorgan is a best-in-class compounding franchise trading at a discount to intrinsic value in the ideal macro regime for money-center banks, with multiple secular growth catalysts and a capital-return flywheel that generates double-digit total returns regardless of multiple expansion.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 315.02 | bullish |
| close_50_sma | 346.91 | bullish |
| close_10_ema | 356.61 | neutral |
| rsi | 55.31 | neutral |
| macd | 2.56 | neutral |
| macds | 3.93 | neutral |
| macdh | -1.38 | bearish |
| boll | 358.11 | neutral |
| boll_ub | 365.99 | neutral |
| boll_lb | 350.23 | neutral |
| atr | 5.81 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price at $335 OR post-GSIB basing pattern
Then: Add remaining 50%
JPM's profitability metrics are exceptional and justify the premium multiple — not expensive, but discounted compounding.
↩ rebuts: “Bear claims of stretched valuation after 158% three-year return”
EV: +Double-digit total return base case (combining ~3-4% EPS accretion from buybacks + ~7% earnings growth + 1.7% dividend yield), with ~27% upside to intrinsic value per Simply Wall St. · concedes: Easy money from the 158% three-year run has been made; GSIB surcharge is a binary event worth respecting; Yellow flag on short-term momentum (not red); Credit normalization scenario worth monitoring (not present today)
JPM is priced for a perfect macro regime at 52-week highs, with one-time-inflated earnings, a $13B GSIB binary event, and technical momentum rolling over — creating asymmetric downside risk that doesn't justify initiating longs at current levels.
· concedes: JPM remains the highest-quality bank franchise; Normalized Q2-26 EPS growth still ~23% YoY — underlying business is strong; 200-day moving average is technically intact; 1.69% dividend yield is correct; No credit deterioration flagged in any recent quarter
→ vs conservative: MACD bearish cross at 2.56 above zero is a coiled spring, not a crack in the foundation; RSI at 55 represents a healthy reset, not a warning
→ vs conservative: Waiting for $346 target represents a strategy designed to feel safe, not to make money; the 50-DMA has already confirmed support twice in August
→ vs conservative: GSIB surcharge $13B capital relief reversal is already priced in as a known overhang; JPM doesn't break 10% on a well-telegraphed regulatory outcome
→ vs conservative: Normalized P/E argument of 16-17x due to Q2-26 unusual items is intellectually dishonest; underlying trajectory of 10% NII growth, 9.3% loan growth, and expanding operating leverage is genuinely powerful
→ vs conservative: The conservative analyst is asking to wait for a multiple that doesn't exist for a franchise this good
→ vs neutral: The '27% intrinsic discount' framing misses that JPM is simply below fair value relative to earnings power and capital return trajectory; the discount is an opportunity, not a risk
→ vs neutral: The '0-8 week catalyst' framing for GSIB risk means any adverse outcome provides clarity and a clean re-entry point before buyback announcements; not a thesis-breaker
→ vs neutral: The neutral analyst is pricing in risks that are already in the stock and leaving money on the table while convincing themselves they're being disciplined
→ vs conservative: Both conservative and neutral stances suffer from 'perfect being the enemy of excellent'; they're conflating caution with prudence
→ vs conservative: Name a specific scenario where JPM underperforms meaningfully from here; downside cases require multiple things to go wrong simultaneously
| vwma | 358.38 | bearish |
Support: 354.22 · 350.23 · 346.91 · 315.02 | Resistance: 359.24 · 362 · 363 · 365.99
JPM remains in a confirmed long-term uptrend with price 13.6% above the 200 SMA ($315.02) and 3.1% above the rising 50 SMA ($346.91). Short-term momentum is neutral-to-cautious: RSI has reset from overbought to neutral (55.31), MACD shows a mild bearish cross (histogram -1.38) but the MACD line remains positive, and VWMA ($358.38) has been declining from its August 20 peak on lighter volume. Bollinger Bands (upper $365.99, middle $358.11, lower $350.23) indicate price is consolidating near the middle band. ATR of $5.81 reflects moderate volatility. Overall bias is constructive on pullbacks; HOLD recommended with trailing stop near $346.91. New positions should wait for breakout above $365.99 with volume confirmation or pullback to $350-355 zone.
Market Capitalization
$950.6 B
Share Price
~$357.6
52-Week High
$366.50
52-Week Low
$279.10
50-Day Moving Avg
$346.72
200-Day Moving Avg
$316.95
P/E (TTM)
15.32x
Forward P/E
14.30x
PEG Ratio
1.74
P/B
2.69x
Beta
0.98
Dividend Yield
1.69%
EPS (TTM)
$23.34
Forward EPS
$25.01
Book Value per Share
$133.01
ROE
17.79%
ROA
1.36%
Net Profit Margin
34.92%
Operating Margin
50.39%
Revenue (TTM)
$186.3B
Q2-26 Revenue
$52.85B
Q2-26 Net Income
$21.16B
Q2-26 EPS
$7.70
Net Interest Income (Q2-26)
$25.51B
Total Assets
$5,015.1 B
Total Liabilities
$4,640.5 B
Total Equity
$374.6 B
Common Equity
$353.6 B
Total Debt
$533.0 B
Long-Term Debt
$460.5 B
Net Loans
$1,516.3 B
Cash & Equivalents
$309.8 B
Trading Securities
$794.2 B
Held-to-Maturity Securities
$268.5 B
Tangible Book Value
$289.3 B
Goodwill & Intangibles
$64.3 B
Retained Earnings
$445.0 B
Treasury Stock
$178.4 B
Net Debt
$223B
Buybacks (5-quarter)
~$33.5B
Dividends (5-quarter)
~$21.5B
Combined Capital Return
~$50B+/year
Q2-26 Effective Tax Rate
23.1%
Strengths
Concerns
JPMorgan Chase posted exceptional Q2-26 results with $52.9B in revenue (+17.8% YoY) and $7.70 EPS, fueled by 10% NII growth and strong loan expansion. The bank maintains best-in-class profitability metrics (17.8% ROE, 34.9% net margins) and deploys ~$50B+ annually in capital return through buybacks and dividends. Despite trading near its 52-week high at 2.7x P/B and 15.3x P/E — premium but justified by quality — the principal near-term risk is NII compression from Fed rate cuts and credit deterioration amid rapid loan growth.
Macro: The macro backdrop is unusually benign with prediction markets pricing an 89% probability of no Fed rate cuts in 2026 and only 8% odds of a US recession. Gold weakness on 'Warsh concerns about inflation' suggests the Fed may be more constrained than markets appreciate. Consumer strength from Walmart, Disney, and Costco supports JPM's card services and retail banking. AI infrastructure capex is the single biggest funding theme in capital markets. The NYSE Financial Index was softer late in the week in line with mild risk-off positioning into month-end.